GLP-1 receptor agonists, including semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro), mimic a natural hormone called GLP-1
Patients with diabetes mellitus taking WEGOVY in combination with insulin or an insulin secretagogue (e.g., sulfonylurea) may have an increased risk of hypoglycemia, including severe hypoglycemia
The skin remodeling that started during weeks six through twelve continues building on itself
Ozempic, a brand name for the injectable form of a drug called semaglutide, i meant to treat type 2 diabetes and it can also suppress the appetite and lead to weight loss
This distributes protein evenly, prevents blood sugar crashes, and avoids overwhelming a stomach that empties 30-40% slower than normal
Glutathione may help lighten the appearance of dark or red stretch marks by inhibiting melanin production and supporting the body's natural inflammatory response